The Epstein-Barr induced receptor 2 (EBI2) is a lymphocyteexpressed orphan seven transmembrane-spanning (7TM) receptor that signals constitutively through G␣ i , as shown, for instance by guanosine 5Ј-O-(3-thio)triphosphate incorporation.
G protein-coupled seven transmembrane ␣-helix-spanning receptors (7TM receptors) constitute one of the largest superfamilies of proteins in the human genome and are targets for Ͼ30% of all drugs on the market. The endogenous ligands are highly diverse and span from photons, metals, nucleotides, biogenic amines, amino acids, peptides, and proteins to lipids, steroids, and Krebs-cycle intermediates. Approximately 750 7TM receptors have been identified in the human genome, including ϳ350 olfactory and ϳ30 other chemosensory receptors. The nonolfactory and nonchemosensory receptors are divided into four families: classes A (rhodopsin-like), B, C, and F/S (Frizzled), of which class A is by far the largest (284 members). The EBI2 receptor was identified in 1993 as one of the most up-regulated genes in lymphocytes infected with Epstein-Barr virus (EBV; hence the name Epstein-Barr induced receptor 2, EBI2) (Birkenbach et al., 1993) . It is expressed predominantly in lymphoid tissue and constitutes one of ϳ150 orphan receptors within class A (Vassilatis et al., 2003) . Despite this, it was recently described to signal with high constitutive activity through G␣ i . Constitutive activity is a well known phenomenon among 7TM receptors, and occurs within wild-type (wt) as well as mutated receptors, although it should be noted that in vitro observed constitutive activity could also result from artificial receptor overexpression (Seifert and WenzelSeifert, 2002) . However, the fact that constitutive activity has been associated with multiple diseases [for instance, retinitis pigmentosa (rhodopsin mutations), pigmentation defects (melanocyte-stimulating hormone receptor muta-tions), and hyperfunctional thyroid adenomas (thyroidstimulating hormone receptor mutations) (Robbins et al., 1993; Parma et al., 1995) ] supports a biological relevance, at least in these receptors. It is noteworthy that constitutive activity is a hallmark for the majority of herpesvirusencoded 7TM receptors, exemplified by the broad-spectrum activity of ORF74 from human herpesvirus 8 and the selective constitutive activity through G␣ i of the EBV-encoded BILF-1 receptor (Bais et al., 1998; Rosenkilde et al., 1999; Beisser et al., 2005; Paulsen et al., 2005) . The Ͼ200-fold induction of EBI2 expression upon EBV cell entry is the only known modulation of EBI2 (Birkenbach et al., 1993) , and the biologic function therefore remains to be described. Because of the orphan status, the only pharmacologic "handle" at present is the constitutive activity.
The molecular mechanism behind 7TM receptor activation has been a major area of research for many years and was advanced by the crystal structure of bovine rhodopsin in 2000 (Palczewski et al., 2000) and the crystal structures of the ␤2-adrenergic receptor published in 2007 (Cherezov et al., 2007; Rasmussen et al., 2007) . Based on these crystals and on mutational analysis with, for example, metal-ion site engineering and disulfide engineering or biophysical experiments in for example rhodopsin and the adrenergic receptors, a toggle switch model has been proposed in which the transmembrane helices move during receptor activation in a way that creates space for the G protein and/or adaptor protein at the intracellular edge, whereas extracellular segments of the helices approach each other (Shi et al., 2002; Hubbell et al., 2003; Elling et al., 2006; Schwartz et al., 2006) .
In the present study, we focus on the molecular mechanism behind the constitutive activity of EBI2 ( Fig. 1) and show, in addition, that this activity can be measured as an increase in GTP␥S-binding in EBI2-expressing lymphocytes and HEK293 cells (Fig. 2) . In contrast to most other rhodopsinlike receptors, EBI2 is not part of any larger subfamily (Vassilatis et al., 2003) , and the closest human homolog is GPR18, with which it shares only 23.1% homology and 40.2% similarity. Although EBI2 lacks obvious homology-partners, it still contains the conserved residues identified in most Fig. 1 . Serpentine (A) and helical wheel (B) models of the human EBI2 receptor. Gray circles indicate mutated residues substituted to either reduce or increase the size of the side chain or to change the charge. Black background with white letter indicates the most conserved residues in each helix. In addition, the positions of the conserved amino acids are indicated next to the black circles.
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at ASPET Journals on April 6, 2017 molpharm.aspetjournals.org other rhodopsin-like 7TM receptors (Asn I:18, Asp II:10, Cys III:01, Trp IV:10, and the three prolines in positions V:16, VI:15, and VII:17) (Fig. 1). [In the text, we use the generic 7TM numbering system suggested by Baldwin (1993) and later modified by Schwartz (1994) , whereas in the tables, we also include the nomenclature suggested by Ballesteros and Weinstein (1995) .] We created 44 mutations in 29 residues located in the transmembrane helices based on the proposed models for receptor activation within class A (Hubbell et al., 2003; Schwartz et al., 2006) (Fig. 1) . The residues were chosen based on their prevalence in class A or their being part of well known functional motifs. Side-chain elimination with Ala substitution was used most frequently. However, in certain cases, we introduced residues with similar chemical properties (for instance, Phe to Trp or Arg to Lys), changed charge (for instance, Arg to Glu), or introduced size in a steric hindrance approach (for instance, introduction of Trp). Consistent with the current models for receptor activation, we find that the CWxP motif in TM-6 (in EBI2 CFxP) regulates receptor activation; in addition, we identify Arg 87 (in position II:20) as being important for maintenance of the high constitutive activity of EBI2.
Materials and Methods
Materials. EBI2 was kindly provided by H.R. Luttichau, Laboratory for Molecular Pharmacology, and corresponded to the GenBank accession number L08177. The promiscuous chimeric G protein G␣⌬6qi4myr (abbreviated Gqi4myr) was kindly provided by Evi Kostenis (Rheinische Friedrich-Wilhelm University, Bonn, Germany). Lipofectamine 2000 reagent and Opti-MEM were purchased from Invitrogen (Carlsbad, CA). LucLite (lyophilized substrate solution) was from PerkinElmer Life and Analytical Sciences (Waltham, MA). Goat anti-mouse horseradish peroxidase-conjugated antibody was from Pierce (Rockford, IL), whereas mouse anti-FLAG (M1) antibody, forskolin, and pertussis toxin were from Sigma Chemicals Co. (St. Louis, MO). Both SlowFade Antifade reagent and goat antimouse Alexa Fluor 488-conjugated antibody were from Invitrogen. 3,3Ј,5,5Ј-Tetramethylbenzidine substrate was purchased from KemEnTech (Taastrup, Denmark).
Site-Directed Mutagenesis. All EBI2 constructs were inserted into a modified pcDNA3 vector, kindly provided by Kate Hansen (7TM Pharma, Horsholm, Denmark), which contained an upstream sequence encoding a hemagglutinin signal peptide fused to the FLAG tag. Site-directed mutagenesis was carried out using the Pfu polymerase (Stratagene, La Jolla, CA), and the generated mutations were verified by bidirectional DNA sequencing at MWG Biotech (Martinsried, Germany).
Transfection and Tissue Culture. HEK293 cells were grown in Dulbecco's modified Eagle's medium adjusted to contain 4500 mg/ liter glucose (Invitrogen), 10% fetal bovine serum, 180 u/ml penicillin, and 45 g/ml streptomycin at 10% CO 2 and 37°C. Stably transfected HEK293 cells were grown in the same medium, but with G418 added at 800 mg/ml, as were stably transfected TREX-HEK293 cells but with blasticidin and Zeocin (both from Invitrogen) added at 5 and 100 g/ml, respectively. L1.2 pre-B cells were grown in RPMI 1640 medium supplemented with 10% FBS, 180 u/ml penicillin, 45 g/ml streptomycin, and 800 mg/ml G418 at. For transient transfections, the Lipofectamine 2000 reagent in the serum-free medium Opti-MEM was used according to the manufacturer's description. In brief, the cells were transfected for 5 h at 37°C using Lipofectamine 2000 at 12 l/ml and DNA at varying concentrations and subsequently incubated in fresh growth medium for 48 h before usage. Cells were always transfected in parallel for the CREB luciferase assay and enzyme-linked immunosorbent assay (ELISA). HEK293 and TREX-HEK293 clones stably expressing FLAG-tagged wt EBI2 were generated by transfecting the cells with FLAG-tagged wt EBI2 cloned into pcDNA3.1 or pcDNA4/TO, respectively, and selected using G418 or Zeocin. The L1.2 pre-B cell line stably expressing a wt EBI2-GFP fusion protein was generated as described previously . Membrane Preparation. Membranes were prepared from naive HEK293 cells, HEK293 cells stably expressing FLAG-tagged wt EBI2, naive L1.2 pre-B-cells, L1.2. cells stably expressing C-terminally GFP-tagged wt EBI2, and induced or uninduced TREX-HEK293 stably transfected with FLAG-tagged wt EBI2. In the latter case, the expression of the receptor was induced by incubating the cells in growth medium containing 5 ng/ml doxycycline (Invitrogen) for 48 h. The cells were manually harvested with a rubber policeman in ice-cold PBS and homogenized on ice with the use of a Dounce homogenizer. The homogenate was centrifuged at 500 rpm for 3 min at 4°C. Subsequently, the supernatants were collected and centrifuged at 20,000 rpm at 4°C. The resulting membrane pellets were resuspended in 20 mM HEPES buffer containing 2 mM MgCl 2 and Complete protease inhibitor mixture (Roche, Mannheim, Germany) and kept at Ϫ80°C until subjected to [
35 S]GTP␥S binding experiments. The protein concentrations in each preparation were determined using the BCA protein assay kit (Pierce, Rockford, IL).
[ 35 S]GTP␥S Binding Assay. [ 35 S]GTP␥S binding experiments were carried out in white 96-well plates (NUNC A/S, Roskilde, Denmark) using the scintillation proximity assay-based method. A volume of membrane preparation (corresponding to 20 g protein/well) was diluted in assay buffer (final concentrations: 50 mM HEPES, 2 mM MgCl 2 , 50 mM NaCl, 1 mM EGTA, 1 M GDP, 0.1% BSA, and Complete inhibitor mix). [
35 S]GTP␥S (1250 Ci/mmol; 12.5 mCi/ml; PerkinElmer Life and Analytical Sciences) diluted in assay buffer was added to a final concentration of 1 nM and incubated 30 min at room temperature. Subsequently, wheat germ agglutinin-coupled scintillation proximity assay beads (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK) were added (final concentration, 2.8 mg/ml) followed by 30-min incubation at room temperature on a plate shaker. Finally, the plates were centrifuged at 1500 rpm for 5 min, and the amount of radioactivity determined using a TopCount scintillation counter (PerkinElmer Life and Analytical Sciences). The level of unspecific binding was determined by adding unlabeled GTP␥S at a final concentration of 40 M.
CREB Trans-Reporting Luciferase Assay. The signaling was determined using the trans-reporting CREB-luciferase assay according to the manufacturer's recommendations (Stratagene, La Jolla, CA). Cells were seeded at 8 ϫ 10 4 cells/well in 96-well culture plates 24 h before transfection and were transfected with the trans-activator plasmid pFA2-CREB and the reporter plasmid pFRLUC at 6 ng/8 ϫ 10 4 cells (i.e., 6 ng/well) and 50 ng/8 ϫ 10 4 cells (i.e., 50 ng/well), respectively. In most experiments (Figs. 3-7) , the cells were cotransfected with the chimeric G-protein G␣⌬6qi4myr (abbreviated Gqi4myr) at 30 ng/8 ϫ 10 4 cells, (Kostenis, 2002) . However, as a more direct measurement of cAMP inhibition, forskolin (15 M) was added instead of Gqi4myr, and the effect of increasing concentrations of receptor DNA on cAMP-induced CREB-activation was measured (Fig. 9) in the absence or presence of pertussis toxin (100 ng/ml). The CREB activity was determined 48 h after transfection using the LucLite substrate (PerkinElmer Life and Analytical Sciences). In brief, the cells were washed twice in Dulbecco's PBS (0.9 mM CaCl 2 , 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 0.5 mM MgCl 2 , 137 mM NaCl, and 8.1 mM Na 2 HPO 4 ), and the luminescence was measured in a microplate scintillation and luminescence counter (TopCount) after 10-min incubation in 100 l of Dulbecco's PBS and 100 l of LucLite substrate. Every receptor construct was tested in parallel with EBI2 wt receptor at least thrice in quadruples.
Enzyme-Linked Immunosorbent Assay. HEK293 cells were transiently transfected with the indicated FLAG-tagged EBI2 constructs using Lipofectamine 2000 as described above. Forty-eight hours after transfection, the cells were fixed in 4% glutaraldehyde for 10 min, washed thrice in TBS, and blocked for 30 min with TBS containing 2% BSA. Subsequently, the cells were incubated with mouse anti-FLAG M1 antibody at 2 g/ml for 2 h in TBS supplemented with 1% BSA and 1 mM CaCl 2 . After three washes in TBS containing 1% BSA and 1 mM CaCl 2 , the cells were incubated for 1 h with goat anti-mouse horseradish peroxidase-conjugated antibody diluted 1:1000 in the same buffer as the primary antibody. After washing, the immune reactivity was determined by addition of 3,3Ј,5,5Ј-tetramethylbenzidine according to manufacturer's instructions. All steps were carried out at room temperature.
Data Handling. The relative constitutive activity, given as mean Ϯ S.E.M. in -fold compared with wt, is calculated by normalizing the CREB signaling (CS) to cell surface expression (SE) as measured by ELISA according to the following equations: (1) Constitutive activity (CA) ϭ CS/SE and (2) CA mut,relative ϭ CA mut /CA wt ϭ (CS mut ϫ SE wt )/(SE mut ϫ CS wt ).
Statistical Analysis. All statistical analyses were performed as the Student's t tests.
Immunocytochemistry. HEK293 cells were seeded on poly-Llysine-coated coverslips in six-well plates at 5 ϫ 10 5 cells/well. The following day, the cells were transfected with the indicated FLAGtagged EBI2 constructs at 150 ng/well using Lipofectamine 2000 as described above. Forty-eight hours after transfection, the specimens were fixed in 4% paraformaldehyde for 15 min, washed thrice in TBS, and blocked for 20 min with TBS (0.05 M Tris Base and 0.9% NaCl, pH 7.6) containing 2% BSA. Receptors residing at the cell surface were labeled by incubation with mouse anti-FLAG M1 antibody at 2 g/ml in TBS containing 1% BSA and 1 mM CaCl 2 for 1 h. After three washes with TBS containing 1 mM CaCl 2 , labeled receptors were detected by incubating with goat anti-mouse Alexa Fluor 488-conjugated IgG antibody diluted 1:1000 in TBS containing 1% BSA and 1 mM CaCl 2 for 30 min. After washing, the specimens were mounted in SlowFade Antifade reagent using nail polish as sealing. Mock transfected cells were included to ensure no unspecific binding of either primary or secondary antibodies. All steps were performed at room temperature.
Confocal Microscopy. Confocal microscopy was performed using a LSM 510 laser-scanning unit coupled to an inverted microscope with a 63 ϫ 1.4 NA oil immersion Plan-Apochromat objective (Carl Zeiss GmbH, Jena, Germany). Alexa Fluor 488 was excited using an argon-krypton laser ( ϭ 488 nm), and the emission was collected with a long-pass filter at 505 nm. Images were recorded in 1024 ϫ 1024 pixels and averaged over 16 whole-frame scans.
Results
Constitutive Activity of wt EBI2 through GTP␥S Binding. One of the most widely used methods to determine receptor activation of G proteins is the measurement of [ 35 S]GTP␥S binding. The previously shown constitutive activity of EBI2 through G␣ i (as summarized in Fig. 2 , A and B) was supported by a significant increase in [
35 S]GTP␥S binding in membranes from HEK293 cells stably expressing EBI2 or expressing EBI2 under the tetracycline-inducible promoter (TREX-system) compared with naive HEK293 cells or uninduced EBI2 TREX-HEK293 cells. (Fig. 2C) . This was also shown in membranes from L1.2 lymphocytes stably expressing EBI2 fused with GFP ( Fig.  2D) . In all cases, the receptor was well expressed at the surface as demonstrated by ELISA (HEK293) or confocal microscopy (L1.2) (data not shown).
Structural Motifs of Importance for the Constitutive Activity. No endogenous or exogenous ligands have yet been identified for EBI2. We therefore normalized the signaling activity to surface expression to compare mutations with each other. Consequently, all mutations were created with an N-terminal M1 FLAG tag, which did not affect EBI2 signaling , and the cell-surface expression was quantified in HEK293 cells transiently transfected with 0, 15, and 25 ng of receptor DNA by an ELISA technique using the M1 anti-FLAG antibody as primary and the horseradish peroxidase-conjugated antibody as secondary antibody. The constitutive activity through G␣ i was measured in HEK293 cells as the activation of the transcription factor CREB in the presence of Gqi4myr (a chimeric G␣ subunit that is recognized by G␣ i -coupled receptors but activates G␣ q -regulated downstream pathways) (Kostenis, 2002) at four receptor concentrations (0, 5, 15, and 25 ng/8 ϫ 10 4 cells). For all mutations, the relative constitutive activity was determined by correlating the activity to the surface expression at 15 and 25 ng of receptor DNA/8 ϫ 10 4 cells (Tables 1  and 2 ).
TM-6 Is Involved in the Regulation of Constitutive Activity. The motif including the conserved Pro in TM-6 (CFxP in EBI2) was changed into the most frequently occurring CWxP-motif by mutating PheVI:13 (Phe 257 ) to Trp, F(VI:13)W-EBI2. It is noteworthy that this substitution had no effect on the constitutive activity of EBI2 (Fig. 3A , Table  1 ). In contrast, introduction of Ala substantially increased the activity by 5-to 6-fold, and introducing a polar residue (Cys) resulted in a similar increase (3-to 4-fold) (Fig. 3A , Table 1 ). Contrary to the Trp introduction, which only slightly decreased the surface expression (to 73% of wt EBI2), a huge decrease was observed for the Ala and Cys introductions (7 and 17% of wt EBI2; Fig. 3C , Table 1 ). Despite this, these receptors could still be observed on the surface by confocal microscopy using an antibody against the N-terminal Flag-tag and a secondary Alexa Fluor 488-conjugated antibody (Fig. 3, D 
-F).
Linearity is a prerequisite for the correlation of receptor activity with surface expression. Therefore, before the mutational screening, we performed 12-point gene-dose experiments ranging from 1 to 35 ng of wt EBI2 receptor per 8 ϫ 10 4 cells and determined receptor activity as well as surface expression for all doses. As seen in Fig. 4A , there was an almost linear correlation (r 2 ϭ 0.94) between receptor activity and surface expression within the chosen DNA concentrations (see supplemental Fig. 1, A and B , for the corresponding CREB-activity and expression measurements, respectively). However, at very low (1 ng/8 ϫ 10 4 cells) and very high (30-35 ng/8 ϫ 10 4 cells) DNA concentrations, a tendency of lower activity per expressed molecule was observed. This could be due to a higher threshold for the measurement of activation compared with surface expression for the low DNA concentration, and a saturation of the CREBactivation pathway for the high DNA concentrations. However, at between 5 and 25 ng of receptor DNA, we observed a linearity that validated the correlation of receptor activity with surface expression within these concentrations. Because the increases in relative activity for the Ala and Cys introductions in VI:13 were mainly determined by a very low receptor expression (Fig. 3 , A-C), we included multiple gene doses (see Supplemental Fig. 2 ) for F(VI:13)A-EBI2 and F(VI: 13)C-EBI2 and adjusted to exactly the same expression level as wt EBI2. For identical expression levels (Fig. 4B , white bars), an increase in activity appeared (Fig. 4B , black bars) that was similar to that obtained from the correlation of expression and activity for fixed DNA concentrations (Table  1, Fig. 3A) .
Effect of Aromatic Residues in TM-5 and -6 in the Vicinity of PheVI:13 on EBI2 Signaling. The aromatic molpharm.aspetjournals.org environment surrounding VI:13 in the major binding pocket is important for agonist-dependent, as well as constitutive activity in many receptors (see Discussion). [Due to the orphan status of EBI2, the term "major binding pocket" is used in a broader perspective, as robust experimental evidence support that the helices in rhodopsin-like 7TM receptors form a major and a minor binding pocket (delimited by TM-3 to -7 in the case of the major and TM-1 to -3 and TM-7 for the minor binding pocket).] In TM-5, position V:13 is highly conserved as an aromatic residue being either Phe (70%) or Tyr (11%) as in EBI2 and has been suggested to be part of an aromatic cluster of importance for receptor activity . In EBI2, however, only a 1.4-fold reduction in constitutive activity compared with wt activity was obtained upon substitution of Tyr 205 to Ala, whereas introduction of Phe resulted in a modest increase in the relative activity of 1.4-fold (Table 1) . In TM-6, two other highly conserved aromatic residue important for activity in some receptors (see Discussion) are found in the vicinity of PheVI:13: TyrVI:16 and PheVI:09 located one helical turn above and below, respectively (Fig. 1B) . However, no effect was observed for F(VI:09)A-EBI2 (Fig. 5 , A-C, Table 1 ). In contrast, an Ala-substitution of TyrVI:16 resulted in a decrease in relative constitutive activity of 2.3-fold. A similar decrease (1.9-fold) was obtained by introducing Phe at this position (Fig. 5 , A-C, Table 1 ), indicating that the hydroxyl group influences receptor activity.
CysVI:12 has been suggested to act in concert with the aromatic residue in position VI:13 in the ␤2-adrenergic receptor (that holds a Trp in VI:13) (Shi et al., 2002) . We therefore substituted it to Ala and interestingly observed a large increase in the constitutive activity (2.3-fold relative to wt EBI2) (Table 1) . MetVI:24 is another residue of note in TM-6 as this position very seldom (only in 2%) holds a Met. We therefore introduced an Ala (the most common amino acid at this position) and observed no change in the activity or expression [i.e., no change in the relative constitutive activity (Table 1) ].
Effect of Residues in TM-3, -5, and -7 Facing into the Major Binding Pocket on Receptor Activation. Biophysical evidence indicates that TM-7 and TM-3 move in concert with TM-6 during receptor activation (Farrens et al., 1996) . We therefore substituted a total of six residues in the extracellular segments of these two helices pointing toward the major binding pocket (PheIII:08 and ThrIII:12 in TM-3 and ThrVII:05, ValVII:06, MetVII:09, and AsnVII:12 in TM-7). Collectively, these six Ala mutations had no major effect (a factor of Ͻ1.5) on the relative constitutive activity (Table 1) . In more detail, the residue in III:08 is often aromatic (23%) and as such is part of the aromatic cluster (see Discussion). However, in EBI2, an Ala in III:08 decreased the activity only slightly (1.3-fold), whereas introduction of Tyr resulted in an 1.9-fold increase compared with wt EBI2 (Table 1) . Met infrequently occurs at position VII:09 (1%), which usually contains Ala (40%) or Gly (20%). Nevertheless, substitution to Ala resulted in only a minor decrease in constitutive activity (1.4-fold), whereas introduction of Phe resulted in a minor increase in relative constitutive activity (to 1.1-fold; (1.3-fold of wt EBI2) (Fig. 5D) . The expression levels of these mutations in VII:06 and VII:09 were similar to that of wt EBI2 (Fig. 5F ).
In contrast to TM-3, -6, and -7, the role of TM-5 in receptor activation is poorly defined, although position V:13 may have an important role in some receptors . Position V:12, which protrudes right into the major binding pocket, is conserved as a small amino acid (Gly in 29% and Leu in 14%), and in some receptors, introduction of larger side chains abolishes receptor activity (Jensen et al., 2008) . Despite this, we observed only a minor decrease (1.6-fold) for the substitution of Gly for Trp in V:12 (Table 1) . A similar minor effect was observed for the exchange of Cys in position V:09 (which holds a Cys in only 4%) to Ala (Table 1) .
ArgII:20 Is Important for the Constitutive Activity of EBI2. Emerging evidence suggests that residues pointing into the minor binding pocket or residues located elsewhere in the helices confining the minor binding pocket (TM-1, -2, -3, and -7) are also important for receptor activation (Rosenkilde et al., 1994; Zhou et al., 1994; Govaerts et al., 2001a; Miura and Karnik, 2002; Govaerts et al., 2003) . Position II:20 usually contains an aromatic residue (31%) or a Leu (20%), and only rarely an Arg (7%) or a Lys (4%) (Mirzadegan et al., 2003) . Upon introduction of an Ala in II:20, we observed a substantial decrease (11-fold) in the measured CREB-activity (Fig. 6B) and a 1.4-fold decrease in surface expression (Fig. 6C) . The relative constitutive activity for this mutation was therefore decreased 7.1-fold relative to wt (Fig. 6A) . In contrast, introduction of a charge-conserving Lys had no effect on the activity, whereas introduction of a charge-reversing Glu resulted in a major reduction in activity (3.8-fold) compared with wt EBI2 (Fig. 6A) . Three other residues on the same side of TM-2 were also mutated into Ala (LeuII:17 and PheII:13, located one and two helical turns below ArgII: 20, respectively, and TyrII:24, located one helical turn above) with no effect on the activity of EBI2 (Table 2 ). This clearly indicates that charge is important and that ArgII:20 does not act in concert with any other residues in TM-2 for the maintenance of high constitutive activity. In contrast to the mutations in TM-6 (Figs. 3C and 5C, Table 1), there were no major changes in receptor surface expression for the mutations in TM-2 (Fig. 6C, Table 2 ).
Putative ArgII:20 Electrostatic Partners: Anionic Extracellular Loop-2 Residues. No obvious electrostatic partners for ArgII:20 are present at the same horizontal level in EBI2 (Fig. 1A) . However, in extracellular loop-2 (ECL2), which is constrained near the membrane surface through a disulfide-bridge to the conserved CysIII:01, a total of five Glu residues are present (Fig. 1A) . Glu 183 is located closest to Cys 181 in ECL2 (which forms the disulfide-bridge to CysIII: 01), and was therefore substituted to Ala, (E183A)-EBI2. Although this mutation resulted in a 1.3-fold decrease in the relative constitutive activity, this clearly did not even approach the effect of ArgII:20. Furthermore, the four additional anionic amino acids located either before Cys 181 (Glu 175 and Glu 177 ) or after (Glu 188 and Glu 189 ) were substi- Fig. 3 . PheVI:13 in the conserved CFxP-motif is important for the regulation of constitutive activity. HEK293 cells were transiently transfected with Gqi4myr, the reporter plasmid (CREB/Luc system) and increasing concentrations of FLAG-tagged EBI2 receptor (0, 5, 15, and 25 ng/8 ϫ 10 4 cells). A, the relative constitutive activity of the Ala, Cys, and Trp-introductions in VI:13: F(VI:13A)-, F(VI:13)C-, and F(VI:13)W-EBI2 were calculated from the observed CREB-activation (B), correlated to cell-surface expression (C). The CREB-activation was determined for 0, 5, 15, and 25 ng of receptor/8 ϫ 10 4 cells (B), whereas the cell surface expression was determined at 15 as well as 25 ng of receptor/8 ϫ 10 4 cells. The relative constitutive activity was determined for both concentrations (see Table 1 ), and the values for 15 ng/8 ϫ 10 4 cells are depicted in A. All experiments (in B and C) were performed in parallel, and wt EBI2 was included in all experiments (N Ͼ3). D-F, confocal microscopy of EBI2 wt (D), F(VI:13)A-(E), and F(VI:13)C-EBI2 (F). In brief, HEK293 cells were transiently transfected with 150 ng of receptor /8 ϫ 10 4 cells, fixed 48 h after transfection, and the cell surface EBI2 expression visualized by the anti-FLAG M1 antibody followed by the Alexa Fluor 488-conjugated IgG antibody. The confocal microscopy was performed using a LSM 510 laser scanning unit coupled to an inverted microscope with an oil immersion Plan-Apochromat objective (Carl Zeiss). tuted to Ala in a pair-wise manner with no decrease in the constitutive activity of EBI2 (Table 2 ). In fact, a minor increase was observed for the (E188A;E189A)-EBI2 mutation (1.3-fold compared with wt EBI2). Consequently, the two double mutants were combined with (E183A)-EBI2 creating the two triple-mutants (E175A;E177A;E183)-EBI2 and (E183A;E188A;E189A)-EBI2. The former had the same minor effect as (E183A)-EBI2 (1.4-fold decrease in activity), whereas the latter resulted in a 1.8-fold decrease (Table 2) . All in all, these substitutions indicate that the Glu residues in ECL2 do not act in concert as anionic partners with ArgII20 (Table 2 and Fig. 6A ).
Putative ArgII:20 Hydrogen Bond Interaction Partners: Residues in TM-3 and -7. Due to the rather inconclusive results in identifying anionic partners, we searched for possible hydrogen bond interacting partners in TM-3 and -7 for ArgII:20. In TM-7, AsnVII:10 (Asn 298 ) has the chemical properties and proper horizontal locality to make hydrogen bonds with ArgII:20 and is in fact infrequently occurring at this position (1%). However, Ala introduction in VII:10 had no effect on the constitutive activity (Table 2) . Two additional residues in TM-7 with hydrogen-bonding capabilities, His-VII:03 (His 293 ) and CysVII:14 (Cys 302 ), were mutated to Ala, yet again with no effect on the activity of EBI2 (Table 2 ). In TM-3, ThrIII:04 is pointing toward TM-7 and TM-2 and is capable of hydrogen bonding. However, no effect was observed upon introduction of Ala (Table 2 ). In contrast, introduction of Glu in III:04 (in an attempt to force TM-3 closer to ArgII:20 through a salt-bridge formation) resulted in a minor increase in activity (1.4-fold).
Beneficial Effect of an Electrostatic Interaction between Position II:20 and III:03. Because of the apparent beneficial effect of a Glu at position III:03, a model was built based upon the crystal structure of rhodopsin using SWISS-MODEL (http://swissmodel.expasy.org/SWISS-MODEL.html) and Deep Viewer ver. 3.7 software, and residues in the proximity of ArgII:20 were identified by increasing the search radius from 1 to 5 Å in steps of 0.5 Å. Using this approach, IleIII:03 appeared at a radius of 4 Å, whereas ThrIII:04 appeared at 4.5 Å. Consequently, IleIII:03 was mutated to Ala, Glu (as an attempt to introduce a salt-bridge to ArgII:20), and Arg (to create repulsion to ArgII:20) (Fig. 6 , D-F). Whereas the Ala introduction had no effect on EBI2 activity, the Glu introduction resulted in a major increase in constitutive activity (4.4-fold relative to wt EBI2) in contrast to a major decrease in case of the Arg in III:03 (4.6-fold) (Fig.  6, D-F) . These results together indicate a possible interaction between ArgII:20 and IleIII:03, in that the introduction of Glu in III:03 (ϩ/Ϫ) increased the constitutive activity through a putatively formed salt-bridge, whereas the Arg introduction at III:03 (ϩ/ϩ) prevented activity through repulsion [(x/y) designates the charges at II:20 (x) and III:03 (y), in which "ϩ" is positive, "Ϫ" is negative, and 0 is neutral].
Exchange of Charges in Position II:20 and III:03. To substantiate the beneficial effect of the (ϩ/Ϫ) electrostatic interactions (Fig. 6D) , we swapped charges (Ϫ/ϩ) by combining the two signaling-deficient single-mutations: R(II:20)E-EBI2 (Ϫ/0) and I(III:03)R-EBI2 (ϩ/ϩ) (Fig. 6 , A and D, respectively). The resulting double mutation (Ϫ/ϩ) increased the constitutive activity 2.7-fold relative to wt (Fig. 7A) , whereas, as expected, the double-mutant (Ϫ/Ϫ) created by Glu introductions at both positions decreased the activity (Fig. 7A) [similar to (ϩ/ϩ); Fig. 6D ]. In contrast to the almost unaltered surface expression for the mutations of ArgII:20 (Fig. 6C) , we observed a huge decrease for the mutations of III:03, especially for the Glu-and Arg-introduction (6.0% and 19% of wt EBI2 expression, respectively) (Fig. 6F) . The double mutations obtained by combining these two mutations with the Glu-substitution of II:20 were predictably equally lowly expressed (6.2 and 7.1% of wt EBI2; Fig. 7C ). Despite this, however, confocal microscopy uncovered visible and reliable surface expression for all four mutations (Fig. 7, D-G) , and adjustment to exactly the same surface expression by varying the DNA concentrations revealed the same phenotype for the mutations in III:03 (Supplemental Fig. 3) . Thus, as summarized in Fig. 8 , these data strongly suggest that the constitutive activity of EBI2 can be regulated through an interaction between II:20 and III:03, because the single-mutation with Glu introduction in III:03 (ϩ/Ϫ) resulted in a 4.5-fold increase in constitutive activity (through electro- Fig. 4 . Correlation of receptor activation and surface expression for multiple DNA concentrations. A, HEK293 cells were transiently transfected with Gqi4myr, the reporter plasmid (CREB/Luc system) and 12 concentrations of FLAG-tagged wt EBI2 receptor (0 -35 ng/8 ϫ 10 4 cells), and the activity was determined in parallel with surface expression for all DNA concentrations. A linear regression of the data is indicated by the line. Supplemental Fig. 1 shows the corresponding individual experiments. B, data extracted from similar gene-dose experiments with the Ala and Cys-introduction in VI:13, where the white columns indicate receptor expression, and the black columns indicate receptor activity. Supplemental Fig. 2 shows the correlation for all included DNA concentrations (n Ͼ 3). The role of TM-6 and residues nearby for 7TM receptor activation. The experiments were performed as described in Fig. 3 . Relative constitutive activity (A), observed CREB-activation (B), and surface expression (C) for the mutations in the two other aromatic residues in TM-6 (PheVI:09 and TyrVI:16). Relative constitutive activity (D), observed CREB-activation (E), and surface expression (F) for the mutations in TM-7 (ValVI:06 and MetVII:09) (n Ͼ 3). Molecular model showing PheVI:13 and the surrounding residues in EBI2 based on the crystal structure of rhodopsin and rendered wih PyMOL software. TM-6 (blue) and TM-7 (gray) are seen from the major binding pocket, with the positions of ProVI:15 and ProVII:17 marked in red. static interactions with Arg II:20) and that these charges could be swapped (Ϫ/ϩ) upon introduction of Glu in II:20 and Arg in III:03 (Ϫ/ϩ). It is noteworthy that the latter doublemutation (Ϫ/ϩ) rescued the activity (Ͼ10-fold) of the corresponding signaling-deficient single-mutations (Ϫ/0) and (ϩ/ϩ) that exhibited a 3.8-to 4.5-fold decrease in activity compared with wt EBI2 to a 2.7-fold increase in the relative constitutive activity relative to wt (Fig. 8) . Thus, the charge "swapping" (ϩ/Ϫ) to (Ϫ/ϩ) resulted in an increase in constitutive to almost the same levels as the (ϩ/Ϫ). The difference in activity between (ϩ/Ϫ) and (Ϫ/ϩ) is probably due to the effect of ArgII:20 (Fig. 6) .
Effect of ArgII:20 on G␣ i Coupling in the Absence of the Promiscuous G-Protein. An additional approach was used to illustrate the effect of ArgII:20: measurements of receptor-mediated inhibition of forskolin-induced cAMP production. The transcription factor CREB was used as a readout for the cAMP levels in HEK293 cells (Fig. 9, A-D) , and the receptor expression was determined in parallel (Fig. 9 , E and F). As seen in Fig. 9A , increasing concentrations of EBI2 DNA (0, 5, 15, and 25 ng/8 ϫ 10 4 cells) inhibited forskolininduced cAMP-production in a gene-dose-dependent manner, and addition of pertussis toxin totally abolished this effect (as expected from the G␣ i nature of EBI2 signaling) (Fig. 9A) . The charge-conserved substitution of ArgII:20 to Lys had no effect on the signaling, whereas introduction of Ala and Glu impaired EBI2 signaling (Fig. 9B) . None of the mutations in position II:20 had any huge effect on receptor expression. Introduction of Arg in position III:03 (ϩ/ϩ) impaired EBI2 signaling (charge-repulsion), whereas a Glu at this position (I(III:03)E (ϩ/Ϫ) increased the signaling to wt levels (Fig.  9C) . Given the very low expression of (I(III:03)E compared with wt (12% of wt; Fig. 9F ), the relative activity for this construct was above wt levels (as observed in Fig. 6D ). The charge-swapping mutation R(II:20)E;I(III:03)R (Ϫ/ϩ) (Fig.  9D ) increased the activity of the two signaling-deficient R(II: 20)E (Ϫ/0) (Fig. 9B ) and I(III:03)R (ϩ/ϩ) (Fig. 9C) , and given the low expression (6% of wt), the relative activity for this construct was above wt levels (as observed in Fig. 7A) . Thus, the effect of ArgII:20, and the beneficial effect of (ϩ/Ϫ) and (Ϫ/ϩ) obtained by measuring cAMP-levels in HEK293 cells (Fig. 9) were similar to the results obtained using the cotransfection with the promiscuous Gqi4myr (Figs. 6 and 7) .
Discussion
The present study focuses on the molecular mechanism behind the constitutive activity of EBI2. Because EBI2 lacks a known ligand, the receptor activity was normalized for surface expression. We analyzed 44 mutations in 29 residues broadly distributed around the major and minor binding pockets and in ECL2 and identified two regions of importance for the constitutive activity. Thus, we found that the middle of TM-6 (CFxP-motif), more specifically PheVI:13, functions as a negative regulator of activity, whereas Arg-II:20 functions in the opposite way.
Quantification of Receptor Activity in the Absence of an Agonist. The level of constitutive activity is usually correlated to the maximum agonist-induced stimulation (Holst et al., 2004; Jensen et al., 2007) . In the absence of agonists, the receptor activity was correlated to cell surface expression determined by ELISA using antibodies against the M1-FLAG-tag (Figs. 3 and 5-7)-a method also used in other studies (Govaerts et al., 2001b; Srinivasan et al., 2007) . Among the multiple receptor DNA concentrations analyzed (Fig. 4A) , we chose 15 and 25 ng/8 ϫ 10 4 cells for the corre- lations. Certain mutations with major effect on receptor activity displayed very low surface expression [for example, Ala and Cys in VI:13 (Fig. 3C ) and Glu and Arg in III:03 (Fig.  6C) ]. However, adjusted to the same expression level, we observed similar activity fluctuations as obtained for the fixed (15 and 25 ng/8 ϫ 10 4 cells) DNA concentrations. Thus, for the two mutations in VI:13, the activity was increased 1.6-to 2.5-fold for equal receptor expression (Fig. 4B , and Supplemental Figure 2 ) compared with 3-to 6-fold obtained from fixed DNA concentrations (Fig. 3A, Table 1 ). Likewise, introduction of Glu in III:03 resulted in a 1.5-to 2-fold increase, whereas Arg decreased the activity 5-fold (Supplemental Figure 3) , compared with the 4-fold increase and 5-fold decrease obtained for fixed DNA concentrations (Fig. 6D, Table 2 ).
The Role of TM-6 and Nearby Residues for 7TM Receptor Activation. Movements of TM-6, and to a lesser extent TM-3 and -7, are essential for receptor activation (Farrens et al., 1996; Kim et al., 2004) . The CWxP-motif in TM-6 has been identified as a key regulator of movements, the Trp residue acting as a rotameric toggle switch -putatively in concert with CysVI:12, as suggested for the ␤2-adrenergic receptor (Shi et al., 2002) , or with PheIII:12, as suggested for the cannabinoid CB1 receptor (McAllister et al., 2004) . Thus, in many receptors, substitution of the aromatic residue in VI:13 results in abolished activity, for example in the amidergic receptors (Shi et al., 2002) , the ghrelin receptor (Holst et al., 2004) , and the CaSR (Ca 2ϩ -sensing receptor) (Petrel et al., 2003) . Position VI:13 in EBI2 contains a Phe that was exchangeable with Trp with no change in constitutive activity (Fig. 3A) and our finding of Phe/TrpVI:13 as a negative regulator (Fig. 3A, Table 1 ) is in clear contrast to these studies; however, several other 7TM receptors have shown the same phenotype as EBI2. For example, in the bradykinin receptor, a Gln substitution of TrpVI:13 creates constitutive activity (Marie et al., 1999) , as does an Ala substitution in CCR8 (Jensen et al., 2007) . Furthermore, Trp-to-Ala substitutions result in increased binding or action of agonists or positive allosteric modulators, for example in the CB1 receptor (McAllister et al., 2004) , in the CXCR3 receptor , and in class C metabotropic glutamate receptor 5 (Muhlemann et al., 2006) . Position VI:13 is part of the aromatic cluster including residues in TM-3, -5, -6, and -7 (e.g., III:08 and III:12, V:13, VI:16, VII:06, and VII:09) with importance for signaling in receptors regulated predominantly by small endogenous ligands (Roth et al., 1997; Shi et al., 2002; Holst et al., 2004; McAllister et al., 2004; Schwartz et al., 2006) . However, in EBI2, we observed only minor decreases in the activity (1.4-to 2-fold compared with wt) for the Ala substitutions of PheIII:08, TyrV:13, and TyrVI:16, indicating that these aromatic side-chains play only minor roles, at least individually (Table 1 ). An interesting observation for these three residues was the rank-order of effect being TyrϾPheϾAla for positions III:08 and VI:16, and PheϾTyrϾAla for VI:13, indicating that hydrophobicity in addition to polarity matters at these positions. The slight increase in activity for the Met substitution to Phe in VII:09 is consistent with the effect of Phe-VII:09 (as part of the aromatic cluster) in the ghrelin receptor ; interestingly, the increased activity observed for the Ala substitution of CysVI:12 has also been observed in the ␤2-adrenergic receptor upon introduction of Thr for CysVI:12 (Shi et al., 2002) .
ArgII:20-A Major Regulatory Switch for the Activity of EBI2. In general, TM-2 is not considered important for 7TM receptor activation and, in fact, not much attention has been paid to helices confining the minor binding pocket (TM-1,-2,-3, and -7). However, our data suggest otherwise . In particular, the beneficial effect of introducing electrostatic interactions between ArgII:20 (in wt EBI2) and Glu in III:03 (ϩ/Ϫ), and the similar beneficial effect of swapping these charges (Ϫ/ϩ), whereby the two signaling-deficient single-mutations (Ϫ/0) and (ϩ/ϩ) were "rescued" (Fig. 8) . In fact, our data do not stand alone. For example, reciprocal mutations between AsnII:16 (Asn 87 ) and AspVII:16 (Asp 318 ) reestablished high-affinity ligand-binding, thereby rescuing the corresponding (deficient) single-mutations in the gonadotropin-releasing hormone receptor (Zhou et al., 1994 ). Another example is the angiotensin receptor type 1, where it was shown that the orientation of TM-2 changed in constitutively active mutations compared with wt (Miura and Karnik, 2002) . Furthermore, the TLP motif (position II:16-18), conserved among most chemokine receptors, has been shown to be important for receptor activation, as mutation of ThrII:16 to Ala or Val impaired agonist-induced activation in CCR5 (Govaerts et al., 2001a) . It is noteworthy that introduction of Lys or Arg, but not Ala in II:16, rendered CCR2 and -5 constitutive active (Arias et al., 2003) . Because position II:16 is located one helical turn below II:20, our data correlate very well with these observations. It is possible that the effect of the positive charges in II:16 or II:20 could be ascribed to interactions with negatively charged lipids in the lipid bilayer.
The interaction between ArgII:20 and IleIII:03 in EBI2 is not of a strong nature (no hydrogen bond interaction or salt-bridge formation between Arg and Ile), as supported by the unchanged constitutive activity for I(III:03)A (Fig. 6D and Table 2 ). It is noteworthy that the importance of TM-II/ TM-III interactions has also been observed in other receptors. Thus in CCR5, an interaction of hydrophobic character was shown between PheII:19 and LeuIII:04, because residue swapping rescued a deficient signaling of both single mutations. It is noteworthy that molecular dynamic simulations indicated that II:20 (Trp in CCR5) created stabilizing aromatic interactions with PheII:19, whereas a Leu in III:03 stabilized LeuIII:04 in TM-3 (Govaerts et al., 2003) . Thus, viewed from a broader perspective, the upper segment of TM-2 is possibly involved in the stabilization of active receptor conformations, yet no consensus sequence is found in this part of TM-2 or in the surrounding helices (Mirzadegan et al., 2003) , which implies that the responsible interaction(s) differ in chemical nature among 7TM receptors. Observations in the NK1 receptor clearly support this notion, because it was shown that Ala substitutions of a series of residues in TM-2 (GluII:10, AsnII:17, AsnII:21, TyrII:24 and AsnII:26) all resulted in an equilibrium-shift between agonist-and antagonist-binding conformations (as measured by B max for radiolabeled agonist and antagonist, respectively)-with ratios of molpharm.aspetjournals.org 1.1 (B max antagonist/B max agonist) for wt NK1 and 4.0 to 18.5 for the TM-2 mutations (Rosenkilde et al., 1994) .
Thus, in summary, the activity of EBI2 is regulated by at least two regions with PheVI:13 and surrounding residues acting as negative regulators, and ArgII:20 acting as a positive regulator.
1 In both regions, it is most likely that the observed effect is due to conformational changes in the receptor and not to a direct interaction with G-proteins in these regions. It is noteworthy that similar effects have been identified in other 7TM receptors for both regions. It is intriguing that the effect of TM-2 is rather similar to that of CCR2 and CCR5, and that the effect of PheVI:13 is similar to that of CCR8 and CXCR3, in that EBI2 has been suggested to belong to the chemokine receptors. However, EBI2 does not contain the Glu in the top of TM-7 (VII:06), or the Glu/Asp and Tyr residues often present in the N termini of chemokine receptors, whereas it does contain part of the conserved TLP in TM-II (ALP in EBI2) and HCC motif in TM-7 (NCC in EBI2). As a final comment, the constitutive active nature of EBI2 implies that it does not "need" any ligand(s) because its activity can be controlled simply by adjusting receptor expression from the promoter region, although the observed increase in constitutive activity suggests that there is still "room" for agonism. Given the cellular expression pattern and the up-regulation by EBV, it is tempting to ascribe EBI2 a future important role as a target for either antiviral or immune therapy. The present uncovering of the molecular mechanisms for EBI2 activation is important from a drug development point of view in that it may facilitate the rational design and development of small-molecule inverse agonists against EBI2. HEK293 cells were transiently transfected with Gqi4myr, reporter plasmid (CREB/Luc system) and 5 different concentrations of FLAG-tagged constructs being 1-10 ng for EBI2 wt and 25-50 ng for the two I(III:03) mutants. The results are pooled raw data ± SEM from 4 independent experiments with corresponding cell surface expression and CREB activity presented on the abscissa and ordinate axes, respectively.
